DTCFF Stock - Defence Therapeutics Inc.
Unlock GoAI Insights for DTCFF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-53,132 | N/A | $-13,823 | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-2,400,986 | $-12,655,802 | $-6,480,635 | $-7,296,264 | $-2,859,254 |
| Net Income | $-2,586,961 | $-13,193,045 | $-6,762,783 | $-7,343,998 | $-2,859,254 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.05 | $-0.30 | $-0.17 | $-0.20 | $-0.11 |
Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biological/biosimilar therapeutic drugs for cancer and infectious diseases. Its proprietary platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. The company focuses on developing dendritic cell cancer vaccines; protein-based vaccine formulation against COVID and infectious diseases; and antibody drug conjugates (ADC) products targeting various cancers. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Visit WebsiteEarnings History & Surprises
DTCFFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Mar 31, 2025 | — | $-0.01 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.01 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 30, 2024 | — | $-0.02 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-0.02 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.14 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.04 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.03 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.03 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.04 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.03 | — | — |
Q2 2022 | Jun 21, 2022 | — | $-0.05 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.04 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.04 | — | — |
Q4 2021 | Nov 26, 2021 | — | $-0.03 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.04 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about DTCFF
What is DTCFF's current stock price?
What is the analyst price target for DTCFF?
What sector is Defence Therapeutics Inc. in?
What is DTCFF's market cap?
Does DTCFF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to DTCFF for comparison